Mass Spectrometry Market: Current Analysis and Forecast (2025-2033)

Global Mass Spectrometry Market Size & Forecast

The global mass spectrometry market was valued at USD 6,710 million in 2024 and is expected to grow to a strong CAGR of around 7.42% during the forecast period (2025- 2033F) owing to the rising adoption of mass spectrometry for testing emerging contaminants across key sectors, increasing R&D investments in pharmaceutical and biotechnology industries and the integration of AI for enhanced data analysis and high-resolution mass spectrometry technologies.

Mass Spectrometry Market Analysis

The expansion in the market is due to the use of mass spectrometers in environmental testing of samples for analytes such as PFAS and microplastics in environmental analysis, which will grow. The pharmaceutical sector's investment in more budget on research and development and government regulation on drug safety will boost demand for mass spectrometers. Greater investments in energy exploration and climate research will drive demand for mass spectrometers. In addition, the sensitive qualitative and quantitative requirements for food and beverage analysis are likely to boost demand in the mass spectrometry market. For instance, in May 2024, Shimadzu Scientific Instruments announced the new LCMS RX series of triple quadrupole mass spectrometry instruments. These advanced systems are supported by integrated hardware and software technologies to ensure reliable and robust results at lower operating costs, even under the most challenging and dynamic laboratory environments.

Global Mass Spectrometry Market Trends

This section discusses the key market trends that are influencing the various segments of the global mass spectrometry market, as found by our team of research experts.

Rising adoption of mass spectrometry for testing emerging contaminants across key sectors Drives Mass Spectrometry Market Growth

Most traditional analytical methods fail to provide the necessary sensitivity for the detection of these contaminants, ranging from pharmaceuticals, pesticides, and microplastics to per- and polyfluoroalkyl substances (PFAS) at trace concentrations. Mass spectrometry, with its sensitivity, selectivity, and capacity to identify and quantify most compounds, has emerged as the method of choice for analysis of these new contaminants in water, food, drugs, and environmental matrices. This increasing demand, fueled by increased legislation and public concern, is largely driving up demand for mass spectrometry solutions.

Mass Spectrometry Industry Segmentation

This section provides an analysis of the key trends in each segment of the global mass spectrometry market report, along with forecasts at the global, regional, and country levels for 2025-2033.

Instruments Segment Dominates the Mass Spectrometry Market.

Based on product category, the market is segmented into instruments, consumables & services. Among these, the instruments segment holds a larger share of the mass spectrometry industry owing to the availability of a large number of companies providing various types of mass spectrometry instruments. The prominent market players provide a large variety of instruments that can be utilized for different applications. 

For instance, in December 2024, Roche announced that it had received CE mark approval for its cobas® Mass Spec solution, including the cobas® i 601 analyser and the first Ionify® reagent pack of four assays for steroid hormones.

The Quadrupole Liquid Chromatography-Mass Spectrometry Segment Dominates the Mass Spectrometry Market.

Based on technology, the market is segmented into quadrupole liquid chromatography-mass spectrometry, gas chromatography-mass spectrometry (GC-MS), Fourier transform-mass spectrometry (FT-MS), time-of-flight mass spectrometry (TOFMS), matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF), magnetic sector mass spectrometry, and others. Among these, quadrupole liquid chromatography-mass spectrometry held the largest share in the market due to the numerous benefits provided by the technique. Manufacturers are coming up with sophisticated instruments to meet these regulations, which demand more precise and trustworthy data for drug testing and safety evaluations. However, the Fourier Transform - Mass Spectrometry (FT-MS) is the most rapidly growing segment and is anticipated to develop at a substantial CAGR during the forecast period. The pharmaceutical and biotechnology industries' growth is a key driver for FT-MS. Researchers need sophisticated mass spectrometry methods to examine large biomolecules such as proteins and nucleic acids, and hence, the demand for FT-MS is increasing in drug development and biomarker discovery.

For instance, in June 2023, Agilent Technologies Inc. announced two new liquid chromatography mass spectrometry systems (LC-MS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TOF.

North America is expected to grow at a considerable rate during the forecast period.

North America is expected to grow with a significant CAGR during the forecast period (2025-2033). The North American mass spectrometry market is moving forward due to the presence of dominant market players, well-established research institutions, pharma companies, and research organizations, along with strong R&D funding opportunities for biotechnology and drug discovery & development. Besides, rising government support also propels the growth of the market. The US, for instance, is an incubator of innovation and investment opportunities for the life sciences, which has huge demand for premium mass spectrometry systems. In addition, North America is underpinned by a robust academia and research ecosystem that encourages mass spectrometry technology development and uptake. For instance, in February 2023, Berkeley-based precision medicine solutions provider Newomics Inc. announced the commercial placement of its 100th mass spectrometry front-end system, which has contributed to successful customer applications in the development of biotherapeutics such as COVID-19 antibodies and gene therapy, blood-based clinical diagnosis, and proteomics research.

The U.S. held a dominant share of the North American mass spectrometry market in 2024

The United States has always maintained a commanding majority of the North American mass spectrometry market due to its robust focus on research and development in most scientific disciplines. Advanced healthcare infrastructure in the country, combined with large investments in biotechnology and pharmaceutical sectors, has driven demand for mass spectrometry technologies. Furthermore, the availability of market-leading manufacturers and a strong base of academic and research organizations has further cemented the U.S.'s position as a market leader in this industry. All these, along with an increasing emphasis on environmental testing and food safety, have ensured the U.S.'s dominance in the mass spectrometry industry.

Mass Spectrometry Industry Competitive Landscape

The global mass spectrometry market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions.

Top Mass Spectrometry Companies

Some major players running in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., AMETEK, Inc., Advion, Inc. (Beijing Bohui Innovat Biotech Grp Co Ltd.), Bruker Corporation, JEOL Ltd., KORE TECHNOLOGY, LECO Corporation, MKS Instruments, and Waters Corporation.

Recent Developments in the Mass Spectrometry Market

• In April 2024, Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to enable the earliest detection of disease, announced a strategic partnership aimed at advancing scientific discovery in the field of biofluid proteomics biomarkers. This collaboration brings together Biognosys’ expertise in unbiased discovery through data-independent acquisition mass spectrometry (DIA-MS) and Alamar’s cutting-edge immunoassays.

• In May 2024, Shimadzu Scientific Instruments announced the new LCMS RX series of triple quadrupole mass spectrometry instruments. These advanced systems are supported by integrated hardware and software technologies to ensure reliable and robust results at lower operating costs, even under the most challenging and dynamic laboratory environments.

Global Mass Spectrometry Market Report Coverage

Reasons to Buy the Mass Spectrometry Market Report:

• The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.

• The report briefly reviews overall industry performance at a glance.

• The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

The global mass spectrometry market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.